Post-Discharge Venous Thromboembolism After Cancer Surgery
Authors:
- Ryan P. MerkowRMRyan P. Merkow
- Karl Y. BilimoriaKBKarl Y. Bilimoria
- Martin D. McCarterMMMartin D. McCarter
- Mark E. CohenMCMark E. Cohen
- Carlton C. BarnettCBCarlton C. Barnett
- Mehul V. RavalMRMehul V. Raval
- Joseph A. CapriniJCJoseph A. Caprini
- Howard S. GordonHGHoward S. Gordon
- Clifford Y. KoCKClifford Y. Ko
- David J. BentremDBDavid J. Bentrem
- 1 July 2011
- journal article
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 254 (1) , 131-137
Abstract
To (1) define the frequency of overall and postdischarge venous thromboembolism (VTE) after cancer surgery, (2) identify VTE risk for individual cancer operations, and (3) assess mortality rates in patients who experienced a VTE. Cancer is a known risk factor for VTE but less is known about VTE risk after specific cancer operations. Moreover, most cancer patients routinely receive VTE prophylaxis postoperatively while in the hospital, but few receive prolonged prophylaxis despite strong evidence it reduces postdischarge events. From 211 ACS NSQIP hospitals, 44,656 patients undergoing surgery for 9 cancers were identified (2006-2008). The frequency of VTE within 30-days of surgery was evaluated by cancer site and categorized as occurring before or after discharge. Multivariable logistic regression models were constructed to assess risk factors associated with VTE. VTE occurred in 1.6% of all patients, most frequently after esophagogastric (4.2%) and hepatopancreaticobiliary (3.6%) surgery. Overall, 33.4% of VTEs occurred postdischarge (from 17.9% for esophagogastric to 100% for endocrine operations). Factors associated with VTE were age (≥65 years), cancer/procedure type, metastatic disease, congestive heart failure, body mass index (BMI; ≥25 kg/m(2)), ascites, thrombocytosis (>400,000 cells/mm(3)), albumin (2 hours; all P < 0.001). Overall VTE was significantly more likely after gastrointestinal, lung, prostate, and ovarian/uterine operations (all P < 0.001). In those experiencing a VTE, mortality increased over 6-fold (8.0% vs. 1.3%; P < 0.001). One-third of VTE events in cancer surgery patients occurred postdischarge. Postoperative VTE was associated with operation type. Routine postdischarge VTE prophylaxis should be considered for high-risk patients.Keywords
This publication has 23 references indexed in Scilit:
- Venous thromboembolism and cancer: a systematic reviewJournal of Thrombosis and Thrombolysis, 2010
- Toward Robust Information: Data Quality and Inter-Rater Reliability in the American College of Surgeons National Surgical Quality Improvement ProgramJournal of the American College of Surgeons, 2010
- Does Surgical Quality Improve in the American College of Surgeons National Surgical Quality Improvement ProgramAnnals of Surgery, 2009
- Pathophysiology of venous thrombosisThrombosis Research, 2009
- Successful Implementation of the Department of Veterans Affairs’ National Surgical Quality Improvement Program in the Private Sector: The Patient Safety in Surgery StudyAnnals of Surgery, 2008
- Prolonged prophylaxis with dalteparin to prevent late thromboembolic complications in patients undergoing major abdominal surgery: a multicenter randomized open‐label studyJournal of Thrombosis and Haemostasis, 2006
- A Clinical Outcome-Based Prospective Study on Venous Thromboembolism After Cancer SurgeryAnnals of Surgery, 2006
- Evaluation of perioperative fatal pulmonary embolism and death in cancer surgical patientsThrombosis and Haemostasis, 2005
- Outcomes and Cost of Deep Venous Thrombosis Among Patients With CancerArchives of internal medicine (1960), 2004
- Duration of Prophylaxis against Venous Thromboembolism with Enoxaparin after Surgery for CancerNew England Journal of Medicine, 2002